Literature DB >> 29657712

Recent advances in understanding the biology of marginal zone lymphoma.

Francesco Bertoni1,2, Davide Rossi1,2, Emanuele Zucca1,2.   

Abstract

There are three different marginal zone lymphomas (MZLs): the extranodal MZL of mucosa-associated lymphoid tissue (MALT) type (MALT lymphoma), the splenic MZL, and the nodal MZL. The three MZLs share common lesions and deregulated pathways but also present specific alterations that can be used for their differential diagnosis. Although trisomies of chromosomes 3 and 18, deletions at 6q23, deregulation of nuclear factor kappa B, and chromatin remodeling genes are frequent events in all of them, the three MZLs differ in the presence of recurrent translocations, mutations affecting the NOTCH pathway, and the transcription factor Kruppel like factor 2 ( KLF2) or the receptor-type protein tyrosine phosphatase delta ( PTPRD). Since a better understanding of the molecular events underlying each subtype may have practical relevance, this review summarizes the most recent and main advances in our understanding of the genetics and biology of MZLs.

Entities:  

Keywords:  extranodal MZL of MALT type; genetics and biology of MZLs; marginal zone lymphoma; nodal MZL; splenic MZL

Year:  2018        PMID: 29657712      PMCID: PMC5874504          DOI: 10.12688/f1000research.13826.1

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


  134 in total

1.  Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.

Authors:  Shaun Rosebeck; Lisa Madden; Xiaohong Jin; Shufang Gu; Ingrid J Apel; Alex Appert; Rifat A Hamoudi; Heidi Noels; Xavier Sagaert; Peter Van Loo; Mathijs Baens; Ming-Qing Du; Peter C Lucas; Linda M McAllister-Lucas
Journal:  Science       Date:  2011-01-28       Impact factor: 47.728

Review 2.  Immunoreceptor signaling.

Authors:  Lawrence E Samelson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-12-01       Impact factor: 10.005

3.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

4.  TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.

Authors:  Keiichiro Honma; Shinobu Tsuzuki; Masao Nakagawa; Sivasundaram Karnan; Yoshifusa Aizawa; Won Seog Kim; Yoon-Duk Kim; Young-Hyeh Ko; Masao Seto
Journal:  Genes Chromosomes Cancer       Date:  2008-01       Impact factor: 5.006

5.  T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.

Authors:  Hongxiang Liu; Hongtao Ye; Agnes Ruskone-Fourmestraux; Daphne De Jong; Stefano Pileri; Christian Thiede; Anne Lavergne; Henk Boot; Giancarlo Caletti; Thomas Wündisch; Thierry Molina; Babs G Taal; Sabattini Elena; Togliani Thomas; Pier Luigi Zinzani; Andreas Neubauer; Manfred Stolte; Rifat A Hamoudi; Ahmet Dogan; Peter G Isaacson; Ming-Qing Du
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

6.  Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.

Authors:  Andrea Rinaldi; Francesco Forconi; Luca Arcaini; Michael Mian; Elena Sozzi; Silvia Zibellini; Luca Baldini; Silvia Franceschetti; Gianluca Gaidano; Roberto Marasca; Manuela Mollejo; Miguel A Piris; Alessandra Tucci; Fabio Facchetti; Govind Bhagat; Riccardo D Favera; Paola M V Rancoita; Emanuele Zucca; Ivo Kwee; Francesco Bertoni
Journal:  Br J Haematol       Date:  2010-12       Impact factor: 6.998

7.  KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.

Authors:  A Clipson; M Wang; L de Leval; M Ashton-Key; A Wotherspoon; G Vassiliou; N Bolli; C Grove; S Moody; L Escudero-Ibarz; G Gundem; K Brugger; X Xue; E Mi; A Bench; M Scott; H Liu; G Follows; E F Robles; J A Martinez-Climent; D Oscier; A J Watkins; M-Q Du
Journal:  Leukemia       Date:  2014-11-27       Impact factor: 11.528

8.  DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.

Authors:  Alberto J Arribas; Andrea Rinaldi; Afua A Mensah; Ivo Kwee; Luciano Cascione; Eloy F Robles; Jose A Martinez-Climent; David Oscier; Luca Arcaini; Luca Baldini; Roberto Marasca; Catherine Thieblemont; Josette Briere; Francesco Forconi; Alberto Zamò; Massimiliano Bonifacio; Manuela Mollejo; Fabio Facchetti; Stephan Dirnhofer; Maurilio Ponzoni; Govind Bhagat; Miguel A Piris; Gianluca Gaidano; Emanuele Zucca; Davide Rossi; Francesco Bertoni
Journal:  Blood       Date:  2015-01-22       Impact factor: 22.113

9.  TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.

Authors:  Keiichiro Honma; Shinobu Tsuzuki; Masao Nakagawa; Hiroyuki Tagawa; Shigeo Nakamura; Yasuo Morishima; Masao Seto
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

10.  Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.

Authors:  Zhaoyang Li; Hongsheng Wang; Liquan Xue; Dong-Mi Shin; Derry Roopenian; Wu Xu; Chen-Feng Qi; Mark Y Sangster; Carlos J Orihuela; Elaine Tuomanen; Jerold E Rehg; Xiaoli Cui; Quangeng Zhang; Herbert C Morse; Stephan W Morris
Journal:  Blood       Date:  2009-08-20       Impact factor: 22.113

View more
  11 in total

1.  G-protein coupled receptor (GPCR) mutations in lymphoid malignancies: linking immune signaling activation and genetic abnormalities.

Authors:  Jose Angel Martinez-Climent
Journal:  Haematologica       Date:  2018-08       Impact factor: 9.941

2.  Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18.

Authors:  Agnieszka Małecka; Jan Delabie; Ingunn Østlie; Anne Tierens; Ulla Randen; Sigbjørn Berentsen; Geir E Tjønnfjord; Gunhild Trøen
Journal:  Blood Adv       Date:  2020-03-24

3.  The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.

Authors:  Marco Magistri; Lanie E Happ; Jeremy Ramdial; XiaoQing Lu; Vasileios Stathias; Kranthi Kunkalla; Nitin Agarwal; Xiaoyu Jiang; Stephan C Schürer; Sander R Dubovy; Jennifer R Chapman; Francisco Vega; Sandeep Dave; Izidore S Lossos
Journal:  Cancer Res Commun       Date:  2021-10-13

4.  Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.

Authors:  Ariela Noy; Sven de Vos; Morton Coleman; Peter Martin; Christopher R Flowers; Catherine Thieblemont; Franck Morschhauser; Graham P Collins; Shuo Ma; Shachar Peles; Stephen D Smith; Jacqueline C Barrientos; Elizabeth Chong; Shiquan Wu; Leo W-K Cheung; Kevin Kwei; Bernhard Hauns; Israel Arango-Hisijara; Robert Chen
Journal:  Blood Adv       Date:  2020-11-24

5.  IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.

Authors:  Massimo Granai; Teresa Amato; Arianna Di Napoli; Raffaella Santi; Federica Vergoni; Gioia Di Stefano; Virginia Mancini; Sofya Kovalchuk; Emanuele Cencini; Alberto Giulio Carta; Sara Aversa; Marita Ziepert; Gabriele Cevenini; Stefano Lazzi; Lorenzo Leoncini; Cristiana Bellan
Journal:  Virchows Arch       Date:  2019-12-04       Impact factor: 4.064

6.  Variant form of hairy cell leukemia.

Authors:  Margaux Wiber; Elsa Maitre; Edouard Cornet; Véronique Salaün; Dina Naguib; Xavier Troussard
Journal:  Clin Case Rep       Date:  2019-05-06

7.  Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis.

Authors:  Barbara Kiesewetter; Wolfgang Lamm; Werner Dolak; Julius Lukas; Marius E Mayerhoefer; Michael Weber; Ana-Iris Schiefer; Christoph Kornauth; Günther Bayer; Ingrid Simonitsch-Klupp; Markus Raderer
Journal:  Br J Haematol       Date:  2019-05-24       Impact factor: 6.998

Review 8.  Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art.

Authors:  Rossella Talotta; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  J Immunol Res       Date:  2019-01-06       Impact factor: 4.818

9.  Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.

Authors:  Luís Alberto de Pádua Covas Lage; Felipe Faganelli Caboclo Dos Santos; Débora Levy; Frederico Rafael Moreira; Samuel Campanelli Freitas Couto; Hebert Fabrício Culler; Renata de Oliveira Costa; Vanderson Rocha; Juliana Pereira
Journal:  BMC Cancer       Date:  2020-08-03       Impact factor: 4.430

Review 10.  Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice.

Authors:  Theresa Weber; Roland Schmitz
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.